Subpart C. Subpart C—Labeling

• § 341.70 - Labeling of OTC drug products containing ingredients that are used for treating concurrent symptoms (in either a single-ingredient or combination drug product).
• § 341.72 - Labeling of antihistamine drug products.
• § 341.74 - Labeling of antitussive drug products.
• § 341.76 - Labeling of bronchodilator drug products.
• § 341.78 - Labeling of expectorant drug products.
• § 341.80 - Labeling of nasal decongestant drug products.
• § 341.85 - Labeling of permitted combinations of active ingredients.
• § 341.90 - Professional labeling.